News Sentiment

1672 sentiment intelligence

Ascletis Pharma Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 57 Balanced news tone 15 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 11.17 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 15

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-3.2% over one week, +11.5% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Is Ascletis Pharma (SEHK:1672) Undervalued As FDA Clears Its ASC35 Obesity Trial?

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -3.2% Price reacting lower
Trend fit Trend inactive 11.5% over four weeks
Fair value 75.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 8
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 15
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 4
Market source 2
BioSpace 2
TradingView 1
BioWorld News 1
thebambooworks.com 1
The Manila Times 1
livetradingnews.com 1

Event Lens

What the news is about

Classified themes
Market update 11
Deals and strategy 2
Earnings 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-15 of 15